Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kitgen Bio-tech, also known as Hangzhou Qitai Biotechnology, is a China-based in vitro diagnostics and life science reagents company focused on supplying core raw materials and related solutions for diagnostic assay developers. The company markets antigens, antibodies, signal detection reagents, fluorescent particles, and research reagents used across ELISA, colloidal gold, and chemiluminescence assay platforms. Public company descriptions position Kitgen as a solution provider to diagnostic reagent manufacturers, hospitals, universities, and research institutions rather than a therapeutic drug developer. Its business appears centered on commercialized research and diagnostic inputs, with manufacturing and sales operations in Hangzhou, Zhejiang. The available evidence suggests it is an active private company with a small employee base and a portfolio of products rather than a disclosed clinical drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kitgen Bio-tech.